STAT+: A controversial drug for premature births, which FDA wants withdrawn, is tied to elevated cancer risk
The key ingredient in a controversial medicine used to prevent premature births is associated with a…
Category: Pharma
STAT+: Hospitals charge insurers and cash-paying patients much more than what Medicare pays for some infused drugs
Nearly a dozen of the highest-rated hospitals in the U.S. charged commercial health insurers and…
STAT+: Pharmalittle: Court rulings on 340B drug discounts conflict; Swiss socialists want government to buy Sandoz
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: New court rulings add to the confusing and controversial dispute over a U.S. drug discount program
In the latest twist in a closely watched legal battle, two different federal court judges…
STAT+: Clinical trial sites face challenges in diversifying personnel and participants, study finds
As demands for diversity and equity increase across the globe, a new analysis finds nearly…
STAT+: Pharmalittle: Pfizer pill reduced deaths in newly diagnosed Covid patients; U.S. cancels contract with Emergent
Good morning, and a fine Friday to you from STAT reporter Andrew Joseph, here filling…
STAT+: Alphabet has a new drug discovery company building on DeepMind’s AI chops
Alphabet is plunging into the drug discovery business. Over the last year, the tech behemoth…
.jpg)
STAT+: Pharmalittle: Moderna sees $18 billion in Covid vaccine sales despite production woes; U.K. clears Merck Covid pill
Good morning, folks. And how are you today? We are in fine spirits, thanks to…
STAT+: Alzheimer’s conference preview: Aduhelm debate persists, while field grapples with new targets and directions
When physicians and scientists involved in Alzheimer’s disease gather in Boston next week for an…
STAT+: Pharmalittle: Democrats reach a deal on drug pricing; CDC OKs Pfizer Covid shot for kids ages 5 to 11
Rise and shine, everyone, another busy day is on the way. Yes, indeed, the middle…
STAT+: Pharmalittle: Pfizer expects $36 billion in Covid-19 vaccine sales this year; Dems scramble for a drug-pricing compromise
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right…
STAT+: In a first, a California judge rules drug makers are not liable for the opioid crisis
For the first time, drug makers won a court victory in the massive litigation over…
STAT+: Pharmalittle: Doctors pushing Alzheimer’s drug have ties to Biogen; pharma wins key round in dispute over hospital discounts
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: The Purdue bankruptcy plan was approved to distribute billions. Where is the money?
Nearly two months ago, a U.S. bankruptcy court judge approved a controversial Purdue Pharma plan…
.jpg)
STAT+: Government’s bid to force drug makers to offer discounts to some hospitals was ‘arbitrary and capricious,’ judge rules
After more than a year of controversy, a federal court judge ruled the U.S. government…
STAT+: Pharmalittle: Pelosi tries last-ditch drug pricing proposal; Merck sees up to $7B in Covid pill sales in 2022
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: Biden abandons effort to lower drug prices; cheap antidepressant holds promise in fighting Covid
Top of the morning, and a fine one it is. Clear blue skies and crisp…
Public-private partnership launched to accelerate gene therapies for rare diseases
The National Institutes of Health and U.S. Food and Drug Administration unveiled a public-private partnership…
STAT+: Feds probe Novartis over Entresto marketing and compensation to doctors
In what might become a new scandal for Novartis, federal investigators recently demanded information from…
STAT+: Pharmalittle: FDA panel votes to OK Covid shots for kids; Merck licenses Covid pill to Medicines Patent Pool
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: In a groundbreaking move, Merck and the Medicines Patent Pool ink a licensing deal for a Covid-19 pill
In a notable bid to widen access to Covid-19 remedies, Merck (MRK) agreed to license…
‘A drop in the ocean’: Moderna to donate more Covid-19 shots, BioNTech to produce vaccines in Africa
Seeking to address inequitable access to Covid-19 vaccines, two manufacturers touted plans to either expand…
STAT+: Pharmalittle: FDA panel to review Pfizer Covid shot for kids; Novartis may sell or spin off its Sandoz generic unit
Good morning, everyone, and how are you today? A spot of rain, and then some,…
Latest psilocybin patent highlights the swirling battle over psychedelics intellectual property
One of the leading companies racing to develop psychedelics as legal medicines was granted a…
STAT+: ‘For good rather than evil’: Mark Cuban and an employer’s coalition to launch new PBMs to lower drug costs
As Americans grapple with prescription drug costs, two new companies are being launched in hopes…
STAT+: Pharmalittle: Most pharma money went to Dems holding up drug-pricing reform; European officials raid pharma animal health company
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: Four Democratic senators may delay Medicare drug price reform; Western Covid vaccine stockpiles to hit 600M doses by year’s end
And so, another working week will soon draw to a close. Not a moment too…
STAT+: FDA warns a hospital and two physicians for putting patients at ‘significantly increased’ risk in trials
In harsh tones, U.S. regulators warned a Minnesota hospital and two of its physicians for…
STAT+: Most women had no issues obtaining abortion pill from mail-order pharmacies
Amid national furor over abortion access, a new survey found most women were satisfied with…
STAT+: Pharmalittle: Power for Medicare to negotiate drug prices grows less likely; FDA OKs mix-and-match Covid booster shots
Top of the morning to you. And a fine one it is. Crystal clear blue…
STAT+: Pulling back the curtain: U.K. to launch new system for registering clinical trials automatically
In its latest bid to boost clinical trial transparency, the U.K. government will automatically register…
STAT+: Pharmalittle: Gates commits $120 million to speed generic versions of Merck Covid-19 pill; sales of Biogen Alzheimer’s drug bomb
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: Takeda strikes a rebate deal for lung cancer drug as health plans look to value-based agreements
In another bid to address the cost of prescription medicines, Takeda Pharmaceuticals (TAK) and 32PointHealth…
Gates Foundation will provide $120 million to ensure generic production of Merck’s Covid-19 pill
As concern mounts over access to Covid-19 remedies, the Bill & Melinda Gates Foundation is…
STAT+: Pharmalittle: WHO hopes to buy Covid treatments for $10 a course; Sinema is a big obstacle to drug pricing reform
Rise and shine, another busy day is on the way. However, this is also shaping…
‘Make a gesture of humanity’: Pope Francis urges drug makers to release Covid-19 vaccine patents
Amid controversy over global access to Covid-19 vaccines, Pope Francis lent his moral authority to…
STAT+: FDA approves an interchangeable biosimilar version of Humira, but health care savings are dubious
For the first time, U.S. regulators have approved an interchangeable, biosimilar version of Humira, a…
STAT+: Pharmalittle: Biogen drug for rare form of ALS fails pivotal study; EU criticized over IP stance at WTO
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: FDA panel recommends Moderna Covid booster shots; Biden eyes Califf as FDA commish
And so, another working week will soon draw to a close. Not a moment too…
STAT+: MD Anderson hit with ethics complaint over failure to disclose clinical trial results
An advocacy group has filed an ethics complaint with the University of Texas MD Anderson…
STAT+: Pharmalittle: Biden team warns Moderna over global supplies of Covid-19 shot; Pfizer uses a warranty for refunds when a cancer drug fails
Rise and shine. Another busy day is on the way. Indeed, the official to-do list…
STAT+: Pfizer will use a warranty to refund the cost of a lung cancer drug if it doesn’t work
In an unusual bid to address prescription drug costs, Pfizer (PFE) is promising to offer…
STAT+: Pharmalittle: FDA scientists uncertain about Moderna vaccine boosters; pharma may face stricter rules for supplying meds in the EU
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Pharmalittle: Most Americans support Medicare drug price negotiations; Moderna refuses to share its Covid-19 vaccine secret sauce
Hello, everyone, and nice to see you again after an extended weekend break, which included…
STAT+: Pharmalittle: How COVAX failed on its promise to vaccinate the world; White House close to picking FDA nominee
Good morning, everyone. Damian Garde here, filling in for Ed Silverman on a sunny morning…
STAT+: AbbVie loses a lawsuit over Humira trade secrets it claimed were stolen
In a setback to AbbVie (ABBV), a U.S. federal court judge dismissed a lawsuit in…
STAT+: Europe’s largest clinical trial sponsors are getting better at reporting results
More than two dozen of the largest universities and hospitals in Europe have shown a…
STAT+: Moderna plans a vaccine plant in Africa, but critics say the move isn’t enough to ensure access
Amid intense concern that low-income countries lack access to Covid-19 vaccines, Moderna (MRNA) announced plans…
STAT+: Pharmalittle: White House and Moderna battle over global vaccine donations; Pfizer seeks FDA OK for kids to get its Covid shot
Rise and shine, everyone, another busy day is on the way. This morning is getting…
STAT+: Older Americans bore the brunt of antibiotic-resistant infections, study finds
Older Americans were disproportionately affected by several different types of infection for which antibiotics were…